This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.82% per year. These returns cover a period from January 1, 1988 through October 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
automation: Archive
Will UNH's Optum Insight Spending Translate Into Profit Growth?
by Zacks Equity Research
UnitedHealth is scaling AI solutions across Optum Insight to boost efficiency, improve claims processing and drive long-term growth despite rising costs.
UNHPositive Net Change CNCPositive Net Change ELVPositive Net Change
artificial-intelligence automation insurance medical smart-health
Should You Buy GrafTech International (EAF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EAFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Visa vs. Block: Which Digital Payments Stock Has More Upside?
by Rajshree Sipani
XYZ outshines V with stronger growth prospects, a more attractive valuation and expanding Square and Cash App ecosystems that support its upside potential.
VNegative Net Change XYZNegative Net Change
artificial-intelligence automation banking blockchain business-services cybersecurity dividend-yield e-commerce earnings-surprise fin-tech finance payments saas software
CLS Falls 14.4% in a Week as AI Growth Meets Rising Execution Risks
by Arijit Sarkar
Celestica shares fell 14.4% despite strong Q3 earnings and AI-driven growth, as rising capital spending, cash flow pressures and customer concentration pose risks
CLSPositive Net Change JBLPositive Net Change FLEXPositive Net Change
artificial-intelligence automation tech-stocks
CLS Raises 2026 Outlook as AI Demand Powers an Aggressive 2027 Ramp
by Arijit Sarkar
Celestica raises its 2026 guidance and targets $40B in 2027 revenues as AI demand surges, but rising capital spending and cash flow pressures pose challenges.
CLSPositive Net Change JBLPositive Net Change FLEXPositive Net Change
artificial-intelligence automation communications tech-stocks
ZBRA vs. HON: Which Industrial Automation Stock is a Better Pick?
by Anindya Barman
Zebra Technologies and Honeywell show contrasting growth prospects, automation momentum, cash flow trends and valuations as investors weigh their financial performance.
HONPositive Net Change ZBRANegative Net Change
automation industrial-products
Marriott International (MAR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MARPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
HubSpot (HUBS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HUBSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Keysight's New Testing Solution Advance Data Center Connectivity?
by Zacks Equity Research
KEYS launches a 16-channel interconnect testing system that doubles capacity, supports 1.6T technologies and cuts testing time to minutes.
KEYSPositive Net Change CDNSNegative Net Change VISNNegative Net Change VIAVPositive Net Change
automation communications tech-stocks
Humana Gains From Premium Growth Despite Rising Benefit Costs
by Zacks Equity Research
HUM's surging premiums, Medicare Advantage growth and CenterWell expansion bolster its prospects, but rising benefit costs and expenses pose challenges.
HUMPositive Net Change CNCPositive Net Change ELVPositive Net Change
artificial-intelligence automation insurance medical smart-health